Penbrook Management’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Penbrook Management’s Portfolio CSLT Stock Details CSLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-112,750	Closed	-$296K	–	108
2021 Q2	$296K	Sell	112,750 -1,070	-0.9%	-$1.99K	0.18%	92
2021 Q1	$172K	Hold	113,820	–	–	0.12%	97
2020 Q4	$148K	Hold	113,820	–	–	0.11%	92
2020 Q3	$129K	Buy	113,820 +17,070	+18%	+$18.8K	0.11%	95
2020 Q2	$80K	Hold	96,750	–	–	0.08%	96
2020 Q1	$70K	Sell	96,750 -3,150	-3%	-$3.51K	0.09%	95
2019 Q4	$133K	Sell	99,900 -161,230	-62%	-$225K	0.13%	100
2019 Q3	$368K	Sell	261,130 -2,500	-0.9%	-$4.98K	0.4%	75
2019 Q2	$852K	Sell	263,630 -8,000	-3%	-$27.6K	0.91%	35
2019 Q1	$1.02M	Buy	271,630 +600	+0.2%	+$1.91K	1.06%	31
2018 Q4	$588K	Buy	271,030 +7,500	+3%	+$18.6K	0.67%	48
2018 Q3	$712K	Hold	263,530	–	–	0.68%	53
2018 Q2	$1.12M	Buy	+263,530	New	+$990K	1.08%	33

Other funds holding CSLT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

VMV

Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penbrook Management's CSLT Position: Q3 2021 in Review

Penbrook Management sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2021, closing a stake of 112,750 shares — an estimated $296K sold.

Penbrook Management first reported a position in CSLT in Q2 2018 and held it in 13 quarters. The position peaked at $1.12M in Q2 2018. 106 funds tracked by Wall St. Rank hold CSLT as of Q3 2021.

Penbrook Management reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2021 after selling out during the quarter.
Penbrook Management sold 112,750 CASTLIGHT HEALTH, INC. shares in Q3 2021, an estimated $296K.
Penbrook Management first reported a position in CASTLIGHT HEALTH, INC. in Q2 2018 and held it in 13 quarters.
Penbrook Management's CASTLIGHT HEALTH, INC. position peaked at $1.12M in Q2 2018.
106 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2021.

Based on Penbrook Management's 13F filing for Q3 2021, filed 26 Oct 2021.